• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白聚集途径导致不同细胞毒性寡聚物的形成。

Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers.

机构信息

Department of Chemistry, East Carolina University, Greenville, NC, 27858, USA.

Center of Interdisciplinary Magnetic Resonance (CIMAR), National High Magnetic Field Laboratory (NHMFL), 1800 East, Paul Dirac Dr., Tallahassee, FL, 32310, USA.

出版信息

Sci Rep. 2019 Jan 10;9(1):33. doi: 10.1038/s41598-018-37230-1.

DOI:10.1038/s41598-018-37230-1
PMID:30631096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6328637/
Abstract

Characterization of small oligomers formed at an early stage of amyloid formation is critical to understanding molecular mechanism of pathogenic aggregation process. Here we identified and characterized cytotoxic oligomeric intermediates populated during transthyretin (TTR) aggregation process. Under the amyloid-forming conditions, TTR initially forms a dimer through interactions between outer strands. The dimers are then associated to form a hexamer with a spherical shape, which serves as a building block to self-assemble into cytotoxic oligomers. Notably, wild-type (WT) TTR tends to form linear oligomers, while a TTR variant (G53A) prefers forming annular oligomers with pore-like structures. Structural analyses of the amyloidogenic intermediates using circular dichroism (CD) and solid-state NMR reveal that the dimer and oligomers have a significant degree of native-like β-sheet structures (35-38%), but with more disordered regions (~60%) than those of native TTR. The TTR variant oligomers are also less structured than WT oligomers. The partially folded nature of the oligomeric intermediates might be a common structural property of cytotoxic oligomers. The higher flexibility of the dimer and oligomers may also compensate for the entropic loss due to the oligomerization of the monomers.

摘要

在淀粉样形成的早期阶段形成的小寡聚体的特征对于理解致病聚集过程的分子机制至关重要。在这里,我们鉴定并表征了转甲状腺素蛋白(TTR)聚集过程中形成的细胞毒性寡聚体中间产物。在淀粉样形成条件下,TTR 最初通过外部链之间的相互作用形成二聚体。然后,这些二聚体缔合形成具有球形的六聚体,作为自组装成细胞毒性寡聚体的构建块。值得注意的是,野生型(WT)TTR 倾向于形成线性寡聚体,而 TTR 变体(G53A)则倾向于形成具有孔状结构的环形寡聚体。使用圆二色性(CD)和固态 NMR 对淀粉样中间产物进行结构分析表明,二聚体和寡聚体具有相当程度的天然β-折叠结构(35-38%),但与天然 TTR 相比,无序区域更多(~60%)。TTR 变体寡聚体的结构也不如 WT 寡聚体。寡聚体中间产物的部分折叠性质可能是细胞毒性寡聚体的共同结构特性。二聚体和寡聚体的较高灵活性也可能补偿由于单体寡聚化而导致的熵损失。

相似文献

1
Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers.转甲状腺素蛋白聚集途径导致不同细胞毒性寡聚物的形成。
Sci Rep. 2019 Jan 10;9(1):33. doi: 10.1038/s41598-018-37230-1.
2
Toxic Misfolded Transthyretin Oligomers with Different Molecular Conformations Formed through Distinct Oligomerization Pathways.毒性错误折叠转甲状腺素蛋白寡聚物具有不同的分子构象,通过不同的寡聚化途径形成。
Biochemistry. 2022 Nov 1;61(21):2358-2365. doi: 10.1021/acs.biochem.2c00390. Epub 2022 Oct 11.
3
Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway.酶切破坏 CD 环通过一种常见的转甲状腺素蛋白错误折叠途径促进毒性转甲状腺素蛋白寡聚物的形成。
Biochemistry. 2020 Jun 30;59(25):2319-2327. doi: 10.1021/acs.biochem.0c00079. Epub 2020 Jun 14.
4
Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.致病突变会导致甲状腺素运载蛋白天然β-折叠结构发生部分结构变化,并加速聚集。
Biochemistry. 2017 Sep 12;56(36):4808-4818. doi: 10.1021/acs.biochem.7b00658. Epub 2017 Aug 30.
5
Identification of the interfacial regions in misfolded transthyretin oligomers.鉴定错误折叠转甲状腺素蛋白寡聚物的界面区域。
Biochim Biophys Acta Proteins Proteom. 2024 Sep 1;1872(5):141027. doi: 10.1016/j.bbapap.2024.141027. Epub 2024 May 23.
6
Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils.沿转甲状腺素蛋白淀粉样原纤维的组装和去组装途径捕获的独特环形寡聚物。
PLoS One. 2012;7(9):e44992. doi: 10.1371/journal.pone.0044992. Epub 2012 Sep 12.
7
Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.通过分析超速离心法对转甲状腺素蛋白酸变性途径的表征:对野生型、V30M和L55P淀粉样原纤维形成的影响
Biochemistry. 1998 Dec 22;37(51):17851-64. doi: 10.1021/bi981876+.
8
Initial conformational changes of human transthyretin under partially denaturing conditions.人甲状腺素运载蛋白在部分变性条件下的初始构象变化
Biophys J. 2005 Jul;89(1):433-43. doi: 10.1529/biophysj.105.059642. Epub 2005 Apr 8.
9
Force spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers.力谱学揭示了转甲状腺素蛋白淀粉样环状寡聚体中存在结构修饰的二聚体。
J Mol Recognit. 2017 Mar;30(3). doi: 10.1002/jmr.2587. Epub 2016 Nov 3.
10
Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture.前纤维状甲状腺素运载蛋白寡聚体和冷藏的天然四聚体甲状腺素运载蛋白在细胞培养中具有细胞毒性。
Biochem Biophys Res Commun. 2008 Dec 26;377(4):1072-8. doi: 10.1016/j.bbrc.2008.10.121. Epub 2008 Nov 5.

引用本文的文献

1
Differentiating the solution structures and stability of transthyretin tetramer complexed with tolcapone and tafamidis using SEC-SWAXS and NMR.使用尺寸排阻色谱-小角X射线散射(SEC-SWAXS)和核磁共振(NMR)技术区分与托卡朋和他氟米特复合的转甲状腺素蛋白四聚体的溶液结构和稳定性。
J Appl Crystallogr. 2025 Jul 8;58(Pt 4):1373-1383. doi: 10.1107/S1600576725004716. eCollection 2025 Aug 1.
2
Identification of the interfacial regions in misfolded transthyretin oligomers.鉴定错误折叠转甲状腺素蛋白寡聚物的界面区域。
Biochim Biophys Acta Proteins Proteom. 2024 Sep 1;1872(5):141027. doi: 10.1016/j.bbapap.2024.141027. Epub 2024 May 23.
3

本文引用的文献

1
hIAPP forms toxic oligomers in plasma.hIAPP 在血浆中形成毒性寡聚物。
Chem Commun (Camb). 2018 May 24;54(43):5426-5429. doi: 10.1039/c8cc03097a.
2
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers.α-突触核蛋白寡聚物导致膜破坏和细胞毒性的结构基础。
Science. 2017 Dec 15;358(6369):1440-1443. doi: 10.1126/science.aan6160.
3
Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.致病突变会导致甲状腺素运载蛋白天然β-折叠结构发生部分结构变化,并加速聚集。
Amyloid fibril polymorphism in the heart of an ATTR amyloidosis patient with polyneuropathy attributed to the V122Δ variant.
一名患有由V122Δ变体引起的多神经病的ATTR淀粉样变性患者心脏中的淀粉样纤维多态性。
bioRxiv. 2024 May 10:2024.05.09.593396. doi: 10.1101/2024.05.09.593396.
4
Characterization of α-synuclein oligomers formed in the presence of lipid vesicles.在脂质囊泡存在下形成的α-突触核蛋白寡聚体的表征
Biochem Biophys Rep. 2024 Mar 19;38:101687. doi: 10.1016/j.bbrep.2024.101687. eCollection 2024 Jul.
5
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病的分子机制和新兴疗法。
Heart Fail Rev. 2024 Mar;29(2):511-521. doi: 10.1007/s10741-023-10380-9. Epub 2024 Jan 18.
6
Big versus small: The impact of aggregate size in disease.大与小:聚集大小对疾病的影响。
Protein Sci. 2023 Jul;32(7):e4686. doi: 10.1002/pro.4686.
7
Glucagon-like peptide 1 aggregates into low-molecular-weight oligomers off-pathway to fibrillation.胰高血糖素样肽 1 聚集形成低分子量寡聚体,偏离纤颤途径。
Biophys J. 2023 Jun 20;122(12):2475-2488. doi: 10.1016/j.bpj.2023.04.027. Epub 2023 May 2.
8
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy.转甲状腺素蛋白稳定剂和种子抑制剂作为转甲状腺素蛋白淀粉样心肌病的治疗方法
Pharmaceutics. 2023 Apr 3;15(4):1129. doi: 10.3390/pharmaceutics15041129.
9
Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy.野生型转甲状腺素淀粉样变心肌病中塔法米迪的临床特征、结局和治疗效果。
ESC Heart Fail. 2023 Aug;10(4):2319-2329. doi: 10.1002/ehf2.14380. Epub 2023 Apr 18.
10
The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation.酵母分子伴侣Hsp104影响转甲状腺素蛋白聚集体的形成。
Front Mol Neurosci. 2022 Dec 16;15:1050472. doi: 10.3389/fnmol.2022.1050472. eCollection 2022.
Biochemistry. 2017 Sep 12;56(36):4808-4818. doi: 10.1021/acs.biochem.7b00658. Epub 2017 Aug 30.
4
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.不同的 α-突触核蛋白菌株及其对 α-突触核蛋白病异质性的影响。
Neurobiol Dis. 2018 Jan;109(Pt B):209-218. doi: 10.1016/j.nbd.2017.07.018. Epub 2017 Jul 24.
5
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.蛋白质错误折叠、淀粉样纤维形成与人类疾病:过去十年研究进展综述。
Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115. Epub 2017 May 12.
6
FRET studies of various conformational states adopted by transthyretin.甲状腺素运载蛋白所呈现的各种构象状态的荧光共振能量转移研究。
Cell Mol Life Sci. 2017 Oct;74(19):3577-3598. doi: 10.1007/s00018-017-2533-x. Epub 2017 May 6.
7
Structural Characteristics of α-Synuclein Oligomers.α-突触核蛋白寡聚体的结构特征
Int Rev Cell Mol Biol. 2017;329:79-143. doi: 10.1016/bs.ircmb.2016.08.010. Epub 2016 Oct 31.
8
Solid-State NMR Studies Reveal Native-like β-Sheet Structures in Transthyretin Amyloid.固态核磁共振研究揭示了转甲状腺素蛋白淀粉样蛋白中的类天然β-折叠结构。
Biochemistry. 2016 Sep 20;55(37):5272-8. doi: 10.1021/acs.biochem.6b00649. Epub 2016 Sep 7.
9
Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR.溶液和固态核磁共振揭示的与转甲状腺素蛋白错误折叠和淀粉样蛋白形成相关的结构变化
Biochemistry. 2016 Apr 5;55(13):1941-4. doi: 10.1021/acs.biochem.6b00164. Epub 2016 Mar 23.
10
Amyloid Fibres: Inert End-Stage Aggregates or Key Players in Disease?淀粉样纤维:无活性的终末聚集物还是疾病的关键参与者?
Trends Biochem Sci. 2015 Dec;40(12):719-727. doi: 10.1016/j.tibs.2015.10.002. Epub 2015 Nov 2.